Claudia Leucht
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Antagonizing NRG1-ERBB4 signaling pathway with spironolactone for the treatment of schizophrenia: results of a randomized controlled drug repositioning clinical trial.
Journal: Communications medicine
Published: December 16, 2025
Switching antipsychotics versus continued current treatment in people with non-responsive schizophrenia.
Journal: The Cochrane database of systematic reviews
Published: April 11, 2025
Enhancing mental health care: a problem, resources and goals oriented multidimensional framework (PRoGO).
Journal: European archives of psychiatry and clinical neuroscience
Published: February 26, 2025
Taking uncertainty in the assessment of response into account: An advanced guideline for computing responder rates in clinical trials.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: March 18, 2024
A potential issue with PANSS responder analysis.
Journal: Schizophrenia research
Published: July 20, 2023
Efficacy of oral versus long-acting antipsychotic treatment in patients with early-phase schizophrenia in Europe and Israel: a large-scale, open-label, randomised trial (EULAST).
Journal: The lancet. Psychiatry
Published: August 19, 2022
Negative symptoms, striatal dopamine and model-free reward decision-making in schizophrenia.
Journal: Brain : a journal of neurology
Published: March 24, 2022
Lower cholinergic basal forebrain volumes link with cognitive difficulties in schizophrenia.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: January 20, 2021
Aberrant striatal dopamine links topographically with cortico-thalamic dysconnectivity in schizophrenia.
Journal: Brain : a journal of neurology
Published: April 23, 2020
Are Randomized Controlled Trials on Pharmacotherapy and Psychotherapy for Positive Symptoms of Schizophrenia Comparable? A Systematic Review of Patient and Study Characteristics.
Journal: Schizophrenia bulletin
Published: April 11, 2020
Reducing antipsychotic drugs in stable patients with chronic schizophrenia or schizoaffective disorder: a randomized controlled pilot trial.
Journal: European archives of psychiatry and clinical neuroscience
Published: October 23, 2019
Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-controlled trial.
Journal: Contemporary clinical trials communications
Published: September 01, 2019
Last Updated: 09/26/2026